GlobeNewswire Inc.Sep 30, 4:56 AM ET▲ Positive
Key player with ExPERT platform and recent product launches (ExPERT DTx); actively expanding through partnerships and commercial development; positioned in fastest-growing segments.
MaxCyte news
$1.18+1.72%
Close Sep 29, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive1100% of coverage
Neutral00%
Negative00% of coverage
About MaxCyte
No recent articles focused on MaxCyte.
Also mentions MXCT
Articles that tag MXCT but are mainly about other companies.
BenzingaMay 13, 8:52 AM ET▲ Positive
Reported better-than-expected Q1 financial results, causing shares to jump 11.88%. However, maintains weak long and medium-term price trends.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology